A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples